The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).
Assignment: Each study subject will serve as their own control. Delivery of Interventions: * Prior to the study visit, subjects will undergo a review of their medical history and screening laboratories. * During the study, the subjects will undergo the following: * Undergo q10 min blood sampling for 3 hours * Receive a naloxone bolus at the midpoint of q10 min sampling
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
23
One bolus of naloxone
Massachusetts General Hospital
Boston, Massachusetts, United States
Average Change in Mean Luteinizing Hormone (LH) Value
Change in mean LH before vs. after naloxone bolus
Time frame: Before and after treatment, a 3 hour period on a single study day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.